Literature DB >> 22198726

Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment?

Stefan Tritschler1, Clarissa Mosler, Julia Straub, Alexander Buchner, Alexander Karl, Anno Graser, Christian Stief, Derya Tilki.   

Abstract

OBJECTIVES: To assess the power of multi-detector row computerized tomography (MDCT) in daily routine as a basic staging procedure for the decision on local treatment of patients with bladder cancer. PATIENTS AND METHODS: We retrospectively analysed 276 patients who had undergone radical cystectomy between 2004 and 2008 and correlated the MDCT findings with pathological findings, number of removed lymph nodes and type of urinary diversion.
RESULTS: Accuracy of MDCT in predicting pathological tumour stage was 49% (kappa coefficient, 0.23; P < 0.001). Overstaging occurred in 23.4%, and understaging occurred in 24.7%. Accuracy in predicting lymph node metastases was 54% (kappa coefficient, 0.04; P = 0.297). Overstaging and understaging occurred in 8.3 and 29.4%, respectively. Significantly more ileal conduits were performed in patients with high postoperative pathological tumour stages (P = 0.04) and positive lymph nodes (P = 0.013). In contrast, there was no correlation between preoperative CT tumour/nodal stage and the number of removed lymph nodes (P = 0.44 and P = 0.732, respectively), and between preoperative tumour stage and type of urinary diversion (P = 0.126).
CONCLUSIONS: MDCT as a preoperative staging procedure has a low accuracy in predicting the correct tumour and nodal stage, and therefore, it has little impact on decision-making for local treatment of muscle-invasive bladder cancer during radical cystectomy.

Entities:  

Mesh:

Year:  2011        PMID: 22198726     DOI: 10.1007/s00345-011-0817-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.

Authors:  H W Herr; S M Donat
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

2.  Routine CT scan in cystectomy patients: does it change management?

Authors:  H W Herr
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

3.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.

Authors:  Achim Fleischmann; George N Thalmann; Regula Markwalder; Urs E Studer
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study.

Authors:  Hassan Abol-Enein; Derya Tilki; Ahmed Mosbah; Mahmoud El-Baz; Ahmed Shokeir; Adel Nabeeh; Mohamed A Ghoneim
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

6.  Role of patient-physician dialogue in selecting the type of urinary diversion.

Authors:  Devendar Katkoori; Murugesan Manoharan; Motoo Araki; Mark S Soloway
Journal:  Urol Int       Date:  2010-02-17       Impact factor: 2.089

Review 7.  Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

Authors:  Arnulf Stenzl; Nigel C Cowan; Maria De Santis; Markus A Kuczyk; Axel S Merseburger; Maria José Ribal; Amir Sherif; J Alfred Witjes
Journal:  Eur Urol       Date:  2011-03-23       Impact factor: 20.096

8.  The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.

Authors:  Kang Su Cho; Joo Wan Seo; Sung Jin Park; Young Hoon Lee; Young Deuk Choi; Nam Hoon Cho; Seung Choul Yang; Sung Joon Hong
Journal:  Urol Int       Date:  2009-05-11       Impact factor: 2.089

Review 9.  Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?

Authors:  M Kuczyk; Levent Turkeri; Peter Hammerer; Vincent Ravery
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

Review 10.  The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.

Authors:  Alexander Karl; Peter R Carroll; Jürgen E Gschwend; Ruth Knüchel; Francesco Montorsi; Christian G Stief; Urs E Studer
Journal:  Eur Urol       Date:  2009-01-13       Impact factor: 20.096

View more
  13 in total

Review 1.  Preoperative imaging for staging bladder cancer.

Authors:  Maxim J McKibben; Michael E Woods
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

2.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

3.  [Transitional cell carcinoma of the bladder: bladder-sparing therapy].

Authors:  F Vom Dorp; S Tschirdewahn; T Szarvas; H Rübben; R Kraemer; C Rehme
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

4.  The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma.

Authors:  İsa Burak Güney; Kadir Alper Küçüker; Volkan İzol; Mustafa Kibar
Journal:  Turk J Urol       Date:  2019-11-01

5.  Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography.

Authors:  Martijn P A Starmans; Li Shen Ho; Fokko Smits; Nick Beije; Inge de Kruijff; Joep J de Jong; Diederik M Somford; Egbert R Boevé; Ed Te Slaa; Evelyne C C Cauberg; Sjoerd Klaver; Antoine G van der Heijden; Carl J Wijburg; Addy C M van de Luijtgaarden; Harm H E van Melick; Ella Cauffman; Peter de Vries; Rens Jacobs; Wiro J Niessen; Jacob J Visser; Stefan Klein; Joost L Boormans; Astrid A M van der Veldt
Journal:  J Pers Med       Date:  2022-04-30

6.  Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder.

Authors:  M Grabbert; T Grimm; A Buchner; A Kretschmer; M Apfelbeck; G Schulz; F Jokisch; B-S Schneevoigt; C G Stief; A Karl
Journal:  Int Urol Nephrol       Date:  2017-09-12       Impact factor: 2.370

7.  The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.

Authors:  William P Parker; Philip L Ho; Stephen A Boorjian; Jonathan J Melquist; Prabin Thapa; Jeffrey M Holzbeierlein; Igor Frank; Ashish M Kamat; Eugene K Lee
Journal:  World J Urol       Date:  2016-03-04       Impact factor: 4.226

Review 8.  Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.

Authors:  Michał Frączek; Hubert Kamecki; Anna Kamecka; Roman Sosnowski; Katarzyna Sklinda; Marcin Czarniecki; Leszek Królicki; Jerzy Walecki
Journal:  Transl Androl Urol       Date:  2018-10

Review 9.  Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

Authors:  Valeria Panebianco; Yoshifumi Narumi; Ersan Altun; Bernard H Bochner; Jason A Efstathiou; Shaista Hafeez; Robert Huddart; Steve Kennish; Seth Lerner; Rodolfo Montironi; Valdair F Muglia; Georg Salomon; Stephen Thomas; Hebert Alberto Vargas; J Alfred Witjes; Mitsuru Takeuchi; Jelle Barentsz; James W F Catto
Journal:  Eur Urol       Date:  2018-05-10       Impact factor: 20.096

Review 10.  A pictorial review of bladder cancer nodal metastases.

Authors:  Prasad R Shankar; Daniel Barkmeier; Lubomir Hadjiiski; Richard H Cohan
Journal:  Transl Androl Urol       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.